β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 28418448.
- Also identified by DOI 10.1001/jamainternmed.2017.0608 and PMC identifier 5818837.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This population-based cohort study examines the risk of fetal cardiac malformations associated with maternal β-blocker exposure.
Medical subject headings
- Adrenergic beta-Antagonists
- Heart Defects, Congenital